The cardiotoxicity of adriamycin and daunomycin in children.
Eight (16%) of 50 children receiving adriamycin and 2 (3%) of 60 receiving daunomycin had severe cardiomyopathy with congestive heart failure. All 110 patients received cumulative doses of over 500 mg/m2. The incidence was significantly higher in those who also had incidental cardiac radiation. The electrocardiogram, with few exceptions, provided the first indication of cardiac abnormality. There were no deaths from heart failure. Two had thromboembolic episodes. Recommendations are discussed.
D000293:Adolescent; D002648:Child; D003630:Daunorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D006331:Heart Diseases / Q000139:chemically induced*; D006333:Heart Failure / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D004071:Digitalis Glycosides; D004317:Doxorubicin; D003630:Daunorubicin